Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00995813 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
A Phase 4 study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00995813 is a Phase 4 study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 15 participants.
The verdict
NCT00995813, a Phase 4 study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and immune response of the rotavirus vaccine in infants who have undergone abdominal surgery.
Interventions
- BIOLOGICAL Rotarix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00995813
The ClinicalTrials.gov registry entry for NCT00995813 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rotarix is the first listed.
NCT00995813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00995813 about?
NCT00995813 is a clinical study titled "Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure". The purpose of this study is to assess the safety and immune response of the rotavirus vaccine in infants who have undergone abdominal surgery.
What is the current status of trial NCT00995813?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2009-12. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00995813?
The interventions under investigation include: Rotarix (BIOLOGICAL).
Who is sponsoring clinical trial NCT00995813?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.